Quantitative fetal fibronectin screening in asymptomatic high-risk patients and the spectrum of risk for recurrent preterm delivery
- 31 March 2009
- journal article
- research article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 200 (3), 263.e1-263.e6
- https://doi.org/10.1016/j.ajog.2009.01.018
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- The Contribution of Preterm Birth to Infant Mortality Rates in the United StatesPEDIATRICS, 2006
- General obstetrics: A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET StudyBJOG: An International Journal of Obstetrics and Gynaecology, 2005
- Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranesAmerican Journal of Obstetrics and Gynecology, 2005
- Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic reviewBMJ, 2002
- Frequency of Uterine Contractions and the Risk of Spontaneous Preterm DeliveryThe New England Journal of Medicine, 2002
- The Preterm Prediction Study: Quantitative fetal fibronectin values and the prediction of spontaneous preterm birthAmerican Journal of Obstetrics and Gynecology, 2000
- The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network.American Journal of Public Health, 1998
- The preterm prediction study: Fetal fibronectin testing and spontaneous preterm birthObstetrics & Gynecology, 1996
- Fetal fibronectin in patients at increased risk for premature birthAmerican Journal of Obstetrics and Gynecology, 1994
- Fetal Fibronectin in Cervical and Vaginal Secretions as a Predictor of Preterm DeliveryThe New England Journal of Medicine, 1991